BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9529111)

  • 1. Bordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally.
    Poulain-Godefroy O; Mielcarek N; Ivanoff N; Remoué F; Schacht AM; Phillips N; Locht C; Capron A; Riveau G
    Infect Immun; 1998 Apr; 66(4):1764-7. PubMed ID: 9529111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant activity of free Bordetella pertussis filamentous haemagglutinin delivered by mucosal routes.
    Poulain-Godefroy O; Menozzi FD; Alonso S; Vendeville C; Capron A; Locht C; Riveau G
    Scand J Immunol; 2003 Nov; 58(5):503-10. PubMed ID: 14629622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.
    Renauld-Mongénie G; Mielcarek N; Cornette J; Schacht AM; Capron A; Riveau G; Locht C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7944-9. PubMed ID: 8755582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella pertussis filamentous hemagglutinin delivered by mucosal routes enhances immunoglobulin levels in serum and mucosal fluids.
    Poulain-Godefroy O; Vendeville C; Locht C; Riveau G
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):129-36. PubMed ID: 18680517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.
    Guzman CA; Molinari G; Fountain MW; Rohde M; Timmis KN; Walker MJ
    Infect Immun; 1993 Feb; 61(2):573-9. PubMed ID: 8423087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.
    Mielcarek N; Nordström I; Menozzi FD; Locht C; Holmgren J
    Infect Immun; 2000 Feb; 68(2):485-91. PubMed ID: 10639408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase.
    Kremer L; Riveau G; Baulard A; Capron A; Locht C
    J Immunol; 1996 Jun; 156(11):4309-17. PubMed ID: 8666802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a three-component acellular pertussis vaccine administered at birth.
    Belloni C; De Silvestri A; Tinelli C; Avanzini MA; Marconi M; Strano F; Rondini G; Chirico G
    Pediatrics; 2003 May; 111(5 Pt 1):1042-5. PubMed ID: 12728086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
    Mielcarek N; Riveau G; Remoué F; Antoine R; Capron A; Locht C
    Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies.
    Wilson DR; Siebers A; Finlay BB
    Infect Immun; 1998 Oct; 66(10):4884-94. PubMed ID: 9746593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
    J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and immunologic characterization of a truncated Bordetella bronchiseptica filamentous hemagglutinin fusion protein.
    Keil DJ; Burns EH; Kisker WR; Bemis D; Fenwick B
    Vaccine; 1999 Dec; 18(9-10):860-7. PubMed ID: 10580199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.
    Shahin RD; Amsbaugh DF; Leef MF
    Infect Immun; 1992 Apr; 60(4):1482-8. PubMed ID: 1548072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.
    Mielcarek N; Cornette J; Schacht AM; Pierce RJ; Locht C; Capron A; Riveau G
    Infect Immun; 1997 Feb; 65(2):544-50. PubMed ID: 9009311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
    Jabbal-Gill I; Fisher AN; Rappuoli R; Davis SS; Illum L
    Vaccine; 1998 Dec; 16(20):2039-46. PubMed ID: 9796062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene.
    Kayes SG; Shaneyfelt RC; Monteiro C; O'Brien JJ
    J Parasitol; 1998 Aug; 84(4):764-70. PubMed ID: 9714208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.